TABLE 5.
Pharmacokinetic properties of expanded spectrum NNRTIs
NNRTI | Concn (μM) at 24 h
ina:
|
t1/2 (h) | Free drug concn (nM) at 24 h | t1/2 (h) | Ratio of trough level of free drug in chimpanzees:
IC90 of free drug
|
|||||
---|---|---|---|---|---|---|---|---|---|---|
Rhesus monkey | Chimpanzee | Wild type | K103N | K103N-V108I | K103N-P225H | K103N-L100I | ||||
DPC 082 | 0.64 | 4.7 | 5.9 | 141 | 14.2 | 128 | 13 | 1.2 | 1.5 | 0.5 |
DPC 083 | 6.84 | 7.6 | 24 | 152 | 85.7 | 190 | 14 | 4.3 | 2.8 | 0.2 |
DPC 961 | 0.38 | 12.7 | 4.8 | 191 | 76.0 | 318 | 62 | 16 | 8.3 | 0.6 |
DPC 963 | 0.22 | 6.2 | 4.8 | 174 | 19.6 | 348 | 44 | 13 | 10 | 0.5 |
Efavirenz | 0.36 | 2.7 | NAb | 6–15 | NA | 12–30 | 0.4–0.9 | 0.09–0.2 | 0.07–0.2 | 0.003–0.008 |
Each drug was administered to rhesus monkeys orally at 10 mg/kg. Data for chimpanzees, which were given 2 mg/kg, are extrapolated from data for rhesus monkeys.
NA, not available.